Efficacy and safety of fenofibrate add-on therapy for patients with primary biliary cholangitis and a suboptimal response to UDCA
Weijia Duan(China-Japan Friendship Hospital), Jidong Jia(National Clinical Research Center for Digestive Diseases), Hong You(Harbin Institute of Technology), Qianyi Wang(Capital Medical University), Xiaoming Wang(China-Japan Friendship Hospital), Wei Zhang(Erasmus MC), Xiaoning Wu(First Affiliated Hospital of Xi'an Jiaotong University), Hong Ma(Beijing Friendship Hospital), Yu Wang(China-Japan Friendship Hospital), Xiaojuan Ou(Capital Medical University), Xinyan Zhao(Capital Medical University)
Cited by 29
Related Papers
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
|Journal of Hepatology|2020|346
Impact of Nonoptimal Intakes of Saturated, Polyunsaturated, and Trans Fat on Global Burdens of Coronary Heart Disease
|Journal of the American Heart Association|2016|164
New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment
|Hepatology|2016|156
CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1
|Current Biology|1996|138
Monitoring Cystic Fibrosis Lung Disease by Computed Tomography. Radiation Risk in Perspective
|American Journal of Respiratory and Critical Care Medicine|2014|128